Home LiteratureArticle Details
PMID: 2810338 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.

Journal of medical genetics ·Vol. 26 ·No. 9 ·1989-09-00 ·Pages 553-9

Bakker E, Veenema H, Den Dunnen JT, van Broeckhoven C, Grootscholten PM, Bonten EJ, van Ommen GJ, Pearson PL

Abstract

In 288 Dutch and Belgian Duchenne and Becker muscular dystrophy families, the parental origin of 41 new deletion or duplication mutations was determined. Twenty seven of the new mutations occurred in the maternal X chromosome and nine in the grandmaternal and five in the grandpaternal X chromosome. The grandparental data are compatible with equal mutation rates for DMD in male and female X chromosomes. New mutations were defined by their presence in one or more progeny and absence in the lymphocytes of the mother or the grandparents. In one family a fraction of the maternal lymphocytes was found to carry the mutation, suggesting somatic mosaicism. In six cases out of 41, the mutation was transmitted more than once by a parent in whom the mutation was absent in lymphocytes, suggesting gonadal mosaicism as the explanation for the multiple transmission. Using our data for the recurrence of the mutations among the total of at risk haplotypes transmitted, we arrive at a recurrence risk of 14% for the at risk haplotype. The observation of this high risk of germinal mosaicism is crucially important for all physicians counselling females in DMD families. Recently, germinal mosaicism has been observed also in a number of other X linked and autosomal disorders. The implications and appropriate diagnostic precautions are discussed.

MeSH Terms
DNA Probes Female Genetic Counseling Genetic Testing Haplotypes Humans Male Mosaicism Muscular Dystrophies/genetics Mutation Pedigree Recurrence Risk Factors
Chemicals
DNA Probes
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Bakker E
Department of Human Genetics, Sylvius Laboratories, Leiden, The Netherlands.
Veenema H
Den Dunnen J T
van Broeckhoven C
Grootscholten P M
Bonten E J
van Ommen G J
Pearson P L
References (21)
21 references, click to expand
  1. Germline mosaicism and Duchenne muscular dystrophy mutations.
    Nature. 1987 Oct 8-14;329(6139):554-6 PMID: 2889144
  2. A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male.
    Nature. 1987 Oct 8-14;329(6139):556-8 PMID: 2889145
  3. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs.
    Lancet. 1985 Mar 23;1(8430):655-8 PMID: 2858615
  4. Preferential deletion of exons in Duchenne and Becker muscular dystrophies.
    Nature. 1987 Oct 15-21;329(6140):638-40 PMID: 2821406
  5. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels.
    Nature. 1987 Oct 15-21;329(6140):640-2 PMID: 2889148
  6. Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy.
    Lancet. 1987 Dec 5;2(8571):1294-7 PMID: 2890901
  7. Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.
    Am J Hum Genet. 1988 Feb;42(2):237-48 PMID: 3341380
  8. Germinal mosaicism in Duchenne muscular dystrophy.
    Hum Genet. 1988 Mar;78(3):282-4 PMID: 3346017
  9. A somatic mosaic for haemophilia A detected at the DNA level.
    Mol Biol Med. 1988 Feb;5(1):23-7 PMID: 3131627
  10. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA.
    Am J Med Genet. 1988 Mar;29(3):713-26 PMID: 2897793
  11. Recurrence risks for germinal mosaics.
    Am J Hum Genet. 1971 Mar;23(2):124-34 PMID: 5092478
  12. Gonadal mosaicism and genetic counseling for X-linked recessive lethals.
    Am J Hum Genet. 1974 Mar;26(2):207-22 PMID: 4823029
  13. Prenatal diagnosis of Duchenne dystrophy.
    Lancet. 1985 Apr 13;1(8433):872 PMID: 2858728
  14. Recombination with pERT87 (DXS164) in families with X-linked muscular dystrophy.
    Lancet. 1986 Jul 12;2(8498):104 PMID: 2873362
  15. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.
    Nature. 1986 Oct 16-22;323(6089):646-50 PMID: 3773991
  16. DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure.
    J Med Genet. 1986 Dec;23(6):573-80 PMID: 2879929
  17. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy.
    Hum Genet. 1987 Mar;75(3):221-7 PMID: 2881877
  18. Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.
    N Engl J Med. 1987 Apr 16;316(16):985-92 PMID: 3561454
  19. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.
    Cell. 1987 Jul 31;50(3):509-17 PMID: 3607877
  20. Maternal duplication associated with gene deletion in sporadic hemophilia.
    Am J Hum Genet. 1988 Sep;43(3):274-9 PMID: 2901224
  21. Report of the committee on human gene mapping by recombinant DNA techniques.
    Cytogenet Cell Genet. 1987;46(1-4):390-566 PMID: 3507285
Article Info
Journal
Journal of medical genetics
Abbr.
J Med Genet
ISSN
0022-2593
Published
1989-09-00
Pages
553-9
Language
English
Region
England
NLM ID
2985087R
PMCID
PMC1015693
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com